Back to Authors

Sundar, Shirin V.

Mayo Clinic

University of Kansas Medical Center

Citations 1

The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease
Sundar, Shirin V., Zhou, Julie , Magenheimer, Brenda S., Reif, Gail A. , Georg, Gunda I. , Jakkaraj, Sudhakar , Tash, Joseph S. , Yu, Alan S.L. , Calvet, James P. , Zhou, Julie Xia, Wallace, Darren P , Yu, Alan S L , Li, Xiaogang , Calvet, James P , Wallace, Darren P. , Li, Xiaogang

American Journal of Physiology-Renal Physiology | August 18, 2022 | Volume: 323 | Issue: 4 | Pages: F492-F506

10.1152/ajprenal.00095.2022 Get It

Autosomal dominant polycystic kidney disease (ADPKD) is a renal neoplastic disorder characterized by the formation of large fluid-filled cysts that develop from kidney tubules through abnormal cell proliferation and cyst-filling fluid secretion driven by cAMP-dependent Cl − secretion. This study shows that the lonidamine derivative H2-GMZ inhibits Cl − secretion, cell proliferation, and cyst growth, suggesting that it might have therapeutic value for the treatment of ADPKD.